Mifepristone: all 148 studies that test it
Page 2 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.
- Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days GestationCompletedNCT01856985Phase 4
- Exploring a Patient-centered Approach to Mifepristone Administration in Medical AbortionCompletedNCT01811056Not applicable
- Introducing Mifepristone-Misoprostol for Menstrual Regulation in Public Sector Facilities in BangladeshCompletedNCT01798017Phase 4
- Cervical Preparation for Surgical Abortion at 12-14 Weeks: a Prospective, Randomized, Evaluator-blinded, Multicenter, Controlled Comparison Between Mifepristone, Misoprostol and Their CombinationStatus unknownNCT01795599Phase 3
- Medical Abortion With Mifepristone + Misoprostol (13 - 22 Weeks)CompletedNCT01768299Phase 4
- Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast CancerCompletedNCT01493310Phase 1
- Study on Combined Use of Letrozole, Mifepristone and Misoprostol in Termination of PregnancyStatus unknownNCT01475318Not applicable
- The Effect of Mifepristone on the Expression of Cervical Prostaglandin EP3 ReceptorsTerminatedNCT01224509Not applicable
- Expansion Study of a Simplified Regimen of Medical Abortion Thru 63 Last Menstrual Period (LMP) in TunisiaCompletedNCT01173003Not applicable
- Preoperative Testing of the Anti-Progesterone Mifepristone in Early Stage Breast CancerTerminatedNCT01138553Early Phase 1
- The Extended Gestational Age Medical Abortion StudyCompletedNCT00997347Phase 4
- Uptake and Acceptability of Home-use of Mifepristone for Medical AbortionCompletedNCT00994734Not applicable
- Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))CompletedNCT00969982Not applicable
- Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)TerminatedNCT00957346Phase 3
- Treatment Regimens for Mifegyne and CytotecStatus unknownNCT00920465Phase 3
- Mifepristone 10 or 5 mg for 6 Months to Treat Uterine FibroidsCompletedNCT00886873Phase 2/3
- Efficacy Study of Vaginal Mifepristone to Treat Uterine FibroidsCompletedNCT00881140Phase 2
- Trial of Mifepristone in Combat Veterans With Posttraumatic Stress DisorderStatus unknownNCT00833339Phase 2
- Misopristol Versus Pitocin for Second Trimester AbortionCompletedNCT00784797Phase 4
- Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14 - 21 Weeks LMP): A Randomized-controlled Double-blinded TrialCompletedNCT00784186Not applicable
- A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy VolunteersCompletedNCT00752843Phase 1
- Glucocorticoid Receptor Antagonism in Subclinical CushingsCompletedNCT00721201Phase 1/2
- Mifepristone for Treatment of Uterine FibroidsCompletedNCT00712595Phase 2/3
- A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom IllnessCompletedNCT00691067Phase 4
- Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol AloneCompletedNCT00680394Not applicable
- The Effect of Mifepristone on Uterine Fibroids and Breast TissueCompletedNCT00579475Phase 1
- A Clinical Trial for Post Traumatic Stress DisorderCompletedNCT00554177Phase 1
- Mifepristone for Patients With Endometrial Cancer and LGESSCompletedNCT00505739Phase 2
- Study of 400mcg Versus 800mcg Buccal Misoprostol Following Mifepristone 200mg for Abortion up to 63 Days GestationCompletedNCT00482209Not applicable
- A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight GainCompletedNCT00455442Phase 2
- Cervical Rippening With Antiprogesterone in Midtrimester AbortionsCompletedNCT00410345Phase 4
- Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester InductionCompletedNCT00383032Not applicable
- RU-486 in the Treatment of Bipolar DepressionWithdrawnNCT00359125Phase 2
- Oral Mifepristone and Buccal Misoprostol Administered Simultaneously for Abortion Through 63 Days GestationCompletedNCT00330993Phase 2
- Study of Sublingual Versus Oral Misoprostol Administration Following Mifepristone 200 mg for Abortion up to 63 Days GestationCompletedNCT00286208Not applicable
- Mifepristone at Same Time Multicenter StudyCompletedNCT00269568Phase 4
- A Study on the Efficacy of 10 mg Oral Mifepristone for the Treatment of Symptomatic Uterine LeiomyomasTerminatedNCT00219778Phase 2
- A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00208156Phase 3
- Expectant Versus Immediate Medical Management for the Evacuation of the no Evolutionary Pregnancies Before 13 GWCompletedNCT00190294Phase 4
- Mifepristone and Misoprostol for Fetal DemiseCompletedNCT00177372Phase 4
- An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00146523Phase 3
- Mifepristone (RU-486) in Androgen Independent Prostate CancerCompletedNCT00140478Phase 2
- A United States Study of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00130676Phase 3
- An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128505Phase 3
- A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major DepressionCompletedNCT00128479Phase 3
- Mifepristone as Adjunctive Therapy in Alzheimer's DiseaseTerminatedNCT00105105Phase 2
- Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected PeopleCompletedNCT00099645Phase 1/2
- Clinical Trial of Mifepristone for Bipolar DepressionCompletedNCT00043654Phase 2